Biological and Pharmaceutical Bulletin
Online ISSN : 1347-5215
Print ISSN : 0918-6158
ISSN-L : 0918-6158
Note
Cigarette Smoke Extract of Heated Tobacco Product Induces Necroptosis via Receptor-Interacting Protein 1-Mediated Phosphorylation of Mixed-Lineage Kinase Domain-Like Protein in Vascular Smooth Muscle Cells
Ryosuke Shinkai, Yuichi Mazaki, Syunsuke Hachimori, Haruna Hashikura, Soichi Miwa, Takahiro Horinouchi
Author information
JOURNAL OPEN ACCESS FULL-TEXT HTML
Supplementary material

2026 Volume 49 Issue 3 Pages 520-524

Details
Abstract

Heated tobacco products (HTPs) are alternatives to traditional combustible cigarettes and are designed to reduce the generation of substances harmful to health. Recently, we reported that nicotine- and tar-free cigarette smoke extract (CSE) prepared from HTP aerosols (HTP-CSE) induces ferroptosis and non-ferroptotic cell death in rat vascular smooth muscle A7r5 cells. However, the non-ferroptotic mechanism underlying HTP-CSE-induced cell death remains unclear. Here, we demonstrate that HTP-CSE causes necroptosis, a type of programmed cell death mediated by the receptor-interacting protein kinase 1 (RIPK1)/RIPK3/mixed lineage kinase domain-like protein (MLKL) signaling pathway. Treatment of A7r5 cells with HTP-CSE at concentrations ranging from 10 to 80% for 4 h decreased mitochondrial metabolic activity and increased lactate dehydrogenase leakage in a concentration-dependent manner. The cytotoxic effects at concentrations of 10 and 20% were partially inhibited by Necrostatin-1s, an RIPK1 inhibitor. Treatment with 20% HTP-CSE for 3 h facilitated MLKL phosphorylation, and the phosphorylation level persisted for up to 6 h after HTP-CSE treatment. The facilitation of MLKL phosphorylation in response to 3 h of exposure to 20% HTP-CSE was almost completely depressed by Necrostatin-1s. These results suggest that HTP-CSE activates the RIPK1/MLKL signaling pathway, resulting in necroptosis associated with mitochondrial dysfunction and cell membrane damage.

Fullsize Image
Content from these authors
© 2026 The Author(s).
Published by The Pharmaceutical Society of Japan

This article is licensed under a Creative Commons [Attribution-NonCommercial 4.0 International] license.
https://creativecommons.org/licenses/by-nc/4.0/
Previous article Next article
feedback
Top